Takeda to sell Japanese consumer health unit to Blackstone for $2.3 b

Reuters Tokyo | Updated on August 24, 2020

Takeda has been reducing its OTC assets worldwide   -  REUTERS

Takeda Pharmaceutical Co has agreed to sell its Japanese consumer healthcare business to US investment fund Blackstone Group for 242 billion yen ($2.3 billion), Japan’s largest drugmaker said on Monday.

The sale of Takeda Consumer Healthcare Company, which makes over-the-counter (OTC) drugs and health products, is expected to close by March 31, subject to regulatory closing conditions, the company said in a statement.

Takeda has been reducing its OTC assets worldwide as it seeks to refocus its business and reduce debt after its $59-billion acquisition of Shire.

Published on August 24, 2020

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like